TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in scar severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Renal function injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Endothelium-dependent Dilation (EDD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient outcomes following laparoscopic surgery for achalasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on visual perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of VTE Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Linagliptin AUC 0-72
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metformin AUC0-tz
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linagliptin Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metformin Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Body Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Breast Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Bone Mineral Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cognitive function changes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Type and amount of nasal microbes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: fMRI BOLD signal activation differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Clinical Score (TCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V8 Device Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure gradients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Zinc protoporphyrin from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in serum ferritin from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ECOG
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clearance estimates for each drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Muscle Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrease in Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency and duration of objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of severity of observed adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Indicated Evaluations Completed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical validity of the gastrointestinal neuroendocrine tumor module
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tooth loss rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kidney transplant success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Index Participants Who Were Lice-Free by Day 2 Maintained Through Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of All Participants Who Were Lice-Free by Day 2 Maintained Through Day 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diagnostic accuracy of ATI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hyperglycemic peaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of co-registration software
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal JAWAC signal threshold for detecting obstructive apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Visual Difference in CT versus TEE images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful transition to adult care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: changes in the levels of monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: changes in the levels of macrophages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: changes in the levels of cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent change of FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of hepatitis D virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change From Baseline in Post-bronchodilator Forced Expiratory Volume in 1 Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of Participants With an Adverse Event (AE) Related to a Blood Absolute Neutrophil Count (ANC) of Less Than 1.5x10^9 Cells/L
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-Reported Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Economic Outcomes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve (AUC) Over the Dosing Interval (AUC[0-tau])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC From Time Zero (Pre-dose) Extrapolated to Infinite Time (AUC [0-inf])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minutes of total physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Inflammatory Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of unplanned hospital visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Changes in the number of Participants with anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absolute Change from Baseline Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of anxiety in children undergoing gastroscopies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma inflammatory cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gut microbiota profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Simpson Angus Scale for Extrapyramidal Symptoms (SAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in the Barnes Akathisia Scale (BAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of steps on the Stand Walk Sit Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recognition of renal tumor subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tumor short-term response to therapeutics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumor long-term response to therapeutics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Frequency of positive PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Parasitic load measured by qPCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: rate of cervical dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change from baseline TETRAS performance sub scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression free survival (PFS) in mCRPC
Endpoint domain: Mortality/survival
Primary endpoint: Progression free survival (PFS) in mHSPC
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants With a ≥90% Improvement in Psoriasis Area and Severity Index (PASI 90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Neutrophil to lymphocyte ratio (NLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: functional connectivity between several brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Toxicity related to AlloStim infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to Mediterranean Diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Trimethylamine N-oxide plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Richmond Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psycho social risk assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in MDS-UPDRS Part III score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Rate of mandibular osteomyelitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Permanent opening of the biliary obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cerebral impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful identification of trackable mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Objective Tumor Response Through Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Duration of Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Area Under the Stimulated C-peptide Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Cerebral Emboli During Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in score on the Richards-Campbell sleep questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: ECG variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of Composite Index of Sjogren's syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sleep disturbance
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Forced Expiratory Volume in first second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Chemotherapy-induced nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Disease Activity Score (DAS28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Composite endpoint (vaginal pH, Nugent score, subjective symptoms)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Box and block test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective response to treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Strength Capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Outcome Scale (GOS) at 1 year post-trauma
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Glasgow Outcome Scale (GOS) at 10-15 years post-trauma
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Harvard Trauma Questionnaire (HTQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Portion of subjects reporting adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of Depressive Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of perceived social support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Total Number of Study-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Opioid Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recommended dose (RD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Patient Clearance Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum calcification propensity (T50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Abduction Rotation Pain VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Sessions Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage Who Drop Out
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of 16-Weeks Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of hereditary brain calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measurement of biomarkers of bone turnover, marker #1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement of biomarkers of bone turnover, marker #2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement of biomarkers of bone turnover, marker #3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Occurrence of new-onset chronic medical conditions
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of solicited injection site reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of solicited systemic reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of study vaccine-related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of vaccine-related clinical safety laboratory adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline on the Pure Procrastination Scale (PPS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline on the Procrastination Assessment Scale for Students (PASS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serum levels of LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum levels of HDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: oral morphine equivalent dose-response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients Survival
Endpoint domain: Mortality/survival
Primary endpoint: Nasal resistance to airflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Mean Seated Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Mean Seated Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in forearm blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Social cognition
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Composite Score of death and hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Global assessment (Packer Score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Completion of cervical cancer screening (Pap test)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of mammography test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biodistribution of gallium Ga 68 FAPi-46
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to the first ventilation attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Differences in gene expression in BAT associated genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HI Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Reporting at Least 1 Treatment-emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Core Temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With a Response of CR, CRp, or PR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment-related Non-hematological Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Ventricular volumetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with composite event (BPAR, Graft Loss or Death)
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of Recurrent Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Hepatosplenomegaly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lymphocyte subset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mRNA expression of calcium channel subunits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Hemoglobin Values in the Range of 11-12 g/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Degree of disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head CT scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 8-week Progression-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Revised ALS Functional Rating Scale (ALSFRS-R) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobilization of endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prosthesis adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of CEB in detecting myocardial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fugyl Meyer assessment motor assessment score (FMA 0-66)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wolf Motor Function Test for affected limb (WMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMP-related dose limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting One or More Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Neurotoxicity Grading
Endpoint domain: Adverse events/effects
Primary endpoint: Intra-abdominal adhesion formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time of Occurrence of Maximum Observed Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 13CO2/12CO2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Caregiver perceptions of pain medicine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the concentration-time curve (AUC) from time 0 extrapolated to infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time of dosing to the last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental illness severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patency rate of the AVF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes